CODEX food labeling meeting
This article was originally published in The Tan Sheet
Executive Summary
Biotech, country of origin and quantitative ingredients food labeling and advertising will be discussed during the Codex Committee on Food Labeling's Jan. 19 public meeting, USDA announces. Participants will convene Jan. 19 from 1 pm to 4 pm at FDA's Harvey Wiley Federal Building in College Park, Md. The meeting was scheduled by U.S. Delegate Leslye Fraser, who also serves as associate director for regulations in the Center for Food Safety & Applied Nutrition's Office of Regulations Policy...
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.